NEW DELHI, Jan. 28, 2025 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.
“An estimated 45 million Americans regularly consume nicotine and about 30 million of them smoke, the most harmful form of nicotine consumption,” said Tom Hayes, president of Swedish Match North America, LLC. “The FDA’s decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.”
The FDA authorized the following products:
The FDA’s decision can be found here.
U.S. Marketing Practices Support 21+ Access Only
Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI’s U.S. affiliates are committed to responsible marketing practices focused on limiting access to adults 21 years of age and older. PMI’s U.S. affiliates do not use social media influencers in the U.S. or people under the age of 35 in marketing materials. They also employ independent age-verification systems like “Double Verify” to direct digital advertising to those over 21, and owned digital platforms are age-gated at the point of access and restricted to current nicotine users of legal age. Swedish Match North America is a Manufacturer Advisory Council member of the We Card Program, a national nonprofit serving retailers of age-restricted products, and a founding board member and investor in TruAge®, a free retail technology that provides stores with a more accurate way of age verification, including the ability to detect fake IDs to ensure 21+ access only.
About Philip Morris International
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside tobacco and nicotine sector.
For more information, please visit www.pmi.com and www.pmiscience.com.
View original content:https://www.prnewswire.com/in/news-releases/fda-authorizes-all-zyn-nicotine-pouch-products-currently-marketed-by-swedish-match-in-the-us-302361582.html
January 2025 global sales of 239,571 units, down 2.4% Y/yOutside of Korea, Kia sold 200,993…
The largest competition of young chefs in the world to culminate in Kolkata with a…
ENS Press Contact: Lola Melkonianlola@buzzdistrict.com / +33 6 09 38 67 84Romain Pigenel romain.pigenel@ens.psl.eu Capgemini Press…
ATHENS, Greece, Feb. 02, 2025 (GLOBE NEWSWIRE) -- Circuits Integrated Hellas (CIH), a pioneering innovator…
ROAD TOWN, British Virgin Islands, Feb. 02, 2025 (GLOBE NEWSWIRE) -- RentFi, the first Real…
Transfer of the registered office Paris, France – (31 January 2025) — PROACTIS (ISIN code…